---

$11.89

-0.3750 ( -3.06% ) 323.8K

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-05-19	Buy	5000.00	Zaderej Karen L.
2025-05-15	Buy	5000.00	Zaderej Karen L.
2024-08-21	Buy	12500.00	Zaderej Karen L.
2024-08-21	Buy	5000.00	ANDO GORAN
2024-08-21	Buy	2567.00	DICICCO WENDY F
2024-08-20	Buy	3173.00	Lurker Nancy
2024-07-26	Sale	-1558.00	Lurker Nancy
2024-07-16	Sale	-3250.00	GUYER DAVID R
2024-07-12	Sale	-16666.00	Duker Jay S.
2024-07-12	Sale	-11111.00	Lurker Nancy